3Sixty Public Affairs is a government relations and public
policy consulting firm serving the health and life sciences sectors. We help create bridges between governments, businesses and civil society. 3Sixty provides clients with advocacy solutions, public affairs engagement training and workshops, and research and analysis. We are based in Ottawa, Montreal and Toronto, with strategic partnerships in the rest of the country.
“Meet the Manager: Mitch Moneo – Assistant Deputy Minister, Pharmaceutical Services Division, BC Ministry of Health”, Gerry Jeffcott, Provincial Reimbursement Advisor, November 2018
“Implementing National Pharmacare on Shifting Political Ground”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, November 2018
“20 Years of PRA: Monitoring the Changing Tides of Canadian Pharmaceutical Policy”, Gerry Jeffcott, Provincial Reimbursement Advisor, August 2018
“PharmaFocus 2022”, Gerry Jeffcott, Don Sancton, Bill Dempster and Michel Parent, June 2018
“Why Wait? How Canada’s Reimbursement System Should Prepare Now for New Medicines in the Pipeline and an Aging Population”, Don Sancton and Bill Dempster, Provincial Reimbursement Advisor, May 2018
“Evolution of Pharmaceutical Policy in Canada and a New Triple Aim: Affordability, Accessibility and Appropriateness”, Gerry Jeffcott and Bill Dempster, Provincial Reimbursement Advisor, February 2018
“Perspectives from a Former Provincial Drug Plan Manager”, Gerry Jeffcott, Provincial Reimbursement Advisor, February 2018
“Meet the Manager: Brent Fraser – Vice-President, Pharmaceutical Reviews, CADTH”, Gerry Jeffcott, Provincial Reimbursement Advisor, August 2017
“Building Ethical Relationships Between Pharma & Patient Groups: Opportunities and Challenges”, Philip Delistoyanov and Bill Dempster, Provincial Reimbursement Advisor, August 2017
“PharmaFocus 2021”, Gerry Jeffcott, Alexandra Kyriakos, Rachael Manion, Bill Dempster, Michel Parent and Philip Delistoyanov, June 2017
“The Impact of Changing International Trade Dynamics on the Canadian Pharmaceutical Market”, Gerry Jeffcott, Provincial Reimbursement Advisor, May 2017
“Meet the Manager: Imran Ali – Senior Manager, pan-Canadian Pharmaceutical Alliance office”, Gerry Jeffcott, Provincial Reimbursement Advisor, February 2017
“Pharmaceutical Policy Insights from a Former Provincial Minister of Health”, Gerry Jeffcott, Provincial Reimbursement Advisor, November 2016
“Canadian Orphan Drug Policies: Moving Forward, Slowly”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, November 2016
“Companion Diagnostics for Innovative Pharmaceuticals: Facilitators or Obstacles to Market Access?”, Rachael Manion and Bill Dempster, Provincial Reimbursement Advisor, August 2016
“pCPA Delaying the Start of Negotiations: What Can Be Done?”, Johanne Chambers and Gerry Jeffcott, Provincial Reimbursement Advisor, August 2016
“PharmaFocus 2020”, Gerry Jeffcott, Rachael Manion, Alexandra Kyriakos, Bill Dempster and Michel Parent, June 2016
“Ontario Prepares for Public Drug Program Revamp”, Alexandra Kyriakos and Bill Dempster, Provincial Reimbursement Advisor, May 2016
“Competing Pressures: Market Growth Versus Provincial Budget Constraints”, Gerry Jeffcott, Provincial Reimbursement Advisor, February 2016
“A New Federal Government: Sunny Ways or Gloomy Days Ahead for the Pharmaceutical Industry?”, Bill Dempster and Johanne Chambers, Provincial Reimbursement Advisor, February 2016
“Five Years of the pCPA — Impact and Opportunities for Industry”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, November 2015
“Canada: The Impact on Drug Reimbursement of Healthcare System Reform in Quebec”, Johanne Chambers and Dima Samaha, IMS Pharma Pricing & Reimbursement, September 2015, Vol. 20(9)
“Implementation of Bill C-17 – Impact on Market Access”, Bill Dempster and Rachael Manion, Provincial Reimbursement Advisor, August 2015
“CADTH in Transition: Exploring Reforms to Align Reimbursement Reviews”, Gerry Jeffcott and Johanne Chambers, Provincial Reimbursement Advisor, August 2015
“PharmaFocus 2019”, Gerry Jeffcott, Bill Dempster, Alexandra Kyriakos, Rachael Manion, and Michel Parent, June 2015
“Health System Shake-Up in Quebec – Impact on Drug Reimbursement”, Johanne Chambers and Dima Samaha, Provincial Reimbursement Advisor, May 2015
“How Prescription Drugs are Approved in Canada”, Bill Dempster and Gerry Jeffcott, April 2, 2015
“The IBM Report on the pCPA”, Gerry Jeffcott and Rachael Manion, February 5, 2015
“Therapeutic Reviews: Experience in Canada and Impact on Reimbursement”, Johanne Chambers & William Dempster, IMS Pharma Pricing & Reimbursement, September, 2015, Vol. 19(6)
“CADTH’s New User Fee Policy: How Will it Impact Industry?”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, November 2014
“PharmaFocus 2018”, Gerry Jeffcott, Bill Dempster, Johanne Chambers, and Rachael Manion, June 2014
“Queuing at the Common Drug Review: Why the Long Waits, and What Can Be Done to Eliminate Them?”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, May 2014
“Therapeutic Reviews: Experience in Canada and Impact on Reimbursement”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, February 2014
“Provincial and Federal Elections Aftermath: Impact on the Canadian Reimbursement Landscape”, Bill Dempster and Blake Johnston, Provincial Reimbursement Advisor, February 2012
“The Drug Shortages Challenge: Responses from Governments and Industry”, Bill Dempster, Provincial Reimbursement Advisor, August 2012
“Provincial Purchasing Alliances – Drivers, Challenges and Implications”, Bill Dempster, Provincial Reimbursement Advisor, February 2011